<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="doi: 10.1080/07391102.2020.17791281779128 : Research Article Combined drug repurposing and virtual" exact="screening" post="strategies with molecular dynamics simulation identified potent inhibitors for"/>
 <result pre="4,434,653 confirmed cases and 302,169 deaths are reported. The growing" exact="infection" post="rate and death toll demand the use of all"/>
 <result pre="In this study, we combined drugs repurposing and virtual drug" exact="screening" post="strategies to target 3CLpro, which has an essential role"/>
 <result pre="Communicated by Ramaswamy H. Sarma. Keywords SARS-COV-2 3CLpro drug-repurposing virtual" exact="screening" post="binding free energy Funding Ministry of Science and Technology"/>
 <result pre="concern to humanity, mainly due to the unavailability of proper" exact="treatment" post="(Huang et al., 2020) pushed the investigators to discover"/>
 <result pre="approaches for novel drug development (Zumla et al., 2016) and" exact="testing" post="the efficacy of existing drugs. In one approach, experiments"/>
 <result pre="well known. However, there is a possibility that this â€œbroad-spectrumâ€�" exact="treatment" post="against CoVs would not be effective. In the second"/>
 <result pre="In the second approach, molecular databases were subjected to High-throughput" exact="screening" post="for potential drug molecules to combat infection caused by"/>
 <result pre="subjected to High-throughput screening for potential drug molecules to combat" exact="infection" post="caused by a coronavirus (de Wilde et al., 2014;"/>
 <result pre="was proved successful in the discovery of lopinavir/ritonavir for the" exact="treatment" post="of HIV. Some researchers are using the genomic and"/>
 <result pre="molecules from the marketed drugs or bioactive compounds for effective" exact="treatment" post="of SARS-COV-2. Main-protease or 3CLpro inhibition is a promising"/>
 <result pre="inhibition is a promising target to control the recent SARS-COV-2" exact="infection" post="due to its essential role in viral maturation and"/>
 <result pre="named 3-chymotrypsin-like protease) was subjected to drug repurposing and virtual" exact="screening" post="for potent drug identification followed by molecular dynamics simulation"/>
 <result pre="hope this study will provide useful information for the clinical" exact="treatment" post="of novel coronavirus associated pneumonia. Materials and methods Protein"/>
 <result pre="Literature mining was carried out to collect anti-HIV drugs for" exact="screening" post="against 3CLpro (SARS-COV-2). Multiple drugs were retrieved from drugbank"/>
 <result pre="drugbank database. A total of 31 drugs were shortlisted for" exact="screening" post="against the 3CLpro (SARS-COV-2). High-throughput virtual screening SchrÃ¶dinger binding"/>
 <result pre="were shortlisted for screening against the 3CLpro (SARS-COV-2). High-throughput virtual" exact="screening" post="SchrÃ¶dinger binding site was used for finding the binding"/>
 <result pre="the maps generated by SchrÃ¶dinger Maestro. Three steps of virtual" exact="screening" post="(HTVS, SP, and XP) were used to screen the"/>
 <result pre="against the SARS-COV-2 main protease was carried out using structure-based" exact="screening" post="methods. Anti-HIV drugs such as Lopinavirâ€&quot;Ritonavir are reported to"/>
 <result pre="possess the potential to work against SRS-CoV-2 targets. Therefore, immediate" exact="testing" post="of anti-HIV drugs may lead to a discovery of"/>
 <result pre="residues, are also formed. Thus, we speculate that the clinical" exact="testing" post="of Saquinavir should be done at the earliest. It"/>
 <result pre="the critical active site residues, including His41 and Cys145. Virtual" exact="screening" post="of TCM database against the 3CLpro (SARS-COV-2) Furthermore, we"/>
 <result pre="database against the 3CLpro (SARS-COV-2) Furthermore, we also performed virtual" exact="screening" post="of the Traditional Chinese medicines database (TCM). A total"/>
 <result pre="solvent accessibility. Furthermore, the top five hits from TCM virtual" exact="screening" post="results were also subjected to the free binding energy"/>
 <result pre="to the free binding energy as reported by the virtual" exact="screening" post="results TCM5280805 was reported with the best docking score"/>
 <result pre="from the SARS-COV-2 epidemic, which indicates that the current viral" exact="treatment" post="is not satisfactory, and more diverse studies are needed"/>
 <result pre="of various natural and FDA approved compounds for the effective" exact="treatment" post="of SARS-COV-2. Further, our existing capacity for treating zoonotic"/>
 <result pre="broad-spectrum inhibitors that can reduce the symptoms of human coronavirus" exact="infection" post="remains a formidable subject of study. Considering the time-consuming"/>
 <result pre="3CLpro from SARS-COV-2 using drugs repurposing (anti-HIV drugs) virtual drugs" exact="screening" post="(TCM) approaches to shortlist the most potent compounds for"/>
 <result pre="called the main protease, is an attractive target for the" exact="treatment" post="of SARS-COV-2 because of its role in the viral"/>
 <result pre="that Saquinavir and TCM5280805 should be tested experimentally for possible" exact="treatment" post="of SARS-COV-2. Authors contribution AK, ZB, MK, and SSA"/>
 <result pre="&amp;amp; FriemanM. B. (2014). Repurposing of clinically developed drugs for" exact="treatment" post="of Middle East respiratory syndrome coronavirus infection. Antimicrobial Agents"/>
 <result pre="KaushikA. C., AliS. S., AhmadN., &amp;amp; WeiD.-Q. (2019). Deep-learning-based target" exact="screening" post="and similarity search for the predicted inhibitors of the"/>
 <result pre="WangJ., LiY., &amp;amp; ChenX. (2020). Traditional Chinese medicine in the" exact="treatment" post="of patients infected with 2019-new coronavirus (SARS-CoV-2): a review"/>
</results>
